Bangladesh’s pharmaceutical companies risk losing the chance to produce at least 15 costly biologic drugs royalty-free, as ...

Delhi High Court refuses to direct Zydus to disclose manufacturing process of Sigrima: Gireesh Babu, New Delhi Saturday, July 26, 2025, 08:00 Hrs [IST] The Delhi High Court has sa ...

Jicheng Yang of Wanhuida Intellectual Property considers whether a notable Beijing Intellectual Property Court decision ...

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...

Researchers have demonstrated that microscopic drug delivery containers can be magnetically steered to their targets, ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Biosimilar drugs are drugs that are a lot like biologics, but maybe not identical. Learn why this matters inside.